CommunityDispatch.com
Community News and Information
Google
 
Web communitydispatch.com



search
For More Current News, Click Here

Search








Clinical Trial Studies
RSS Feed RSS Feed
Last Updated: Oct 3rd, 2008 - 11:14:47

                                                                                                                              

Clinical Trial:Relation of Obesity With Frequency of Meals


By Clinical Trial - U.S. National Library of Medicine


Jul 27, 2006, 08:11


Email this article
 Printer friendly page

Relation of Obesity With Frequency of Meals (MST 0557)

This study is currently recruiting patients.
Verified by Rockefeller University July 2006

Sponsored by: Rockefeller University
Information provided by: Rockefeller University
ClinicalTrials.gov Identifier: NCT00229255

Purpose

The purpose of this study is to test the relationship between frequency of meals and hepatic fat content and insulin sensitivity. We hypothesize that low plasma insulin levels (as achieved by periods of fasting) will prevent insulin resistance and reduce hepatic lipid content. In contrast, frequent, carbohydrate-rich meals will predispose to hepatic steatosis (non-alcoholic) and insulin resistance.
Condition Intervention
Obesity
Insulin Resistance
Non-Alcoholic Hepatic Steatosis
 Behavior: Frequency of meals

MedlinePlus related topics:  Metabolic Syndrome X;   Obesity

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment

Official Title: Relation of Obesity With Frequency of Meals (MST 0557)

Further study details as provided by Rockefeller University:

Expected Total Enrollment:  50

Study start: March 2005

The hypothesis will be tested by studying two groups of normal subjects who will receive a defined weight maintenance diet: one group will be given meals twice a day and other group will be given eight meals (snacks) per day. At the beginning of the study period and after 4 weeks following the specified frequency of meals, the study subjects will have their whole body insulin sensitivity and hepatic fat content measured by the euglycemic-hyperinsulinemic clamp and MRI of the liver, respectively.

Eligibility

Ages Eligible for Study:  18 Years   -   45 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  1. Healthy individuals
  2. Age between 18-45 years
  3. BMI between 18.5 – 24.9

Exclusion Criteria:

  1. Diabetes Mellitus
  2. Chronic drug treatment for any medical condition like hypertension or hyperlipidemia, hyperthyroidism or taking weight control medications.
  3. Inability to give informed consent.
  4. Inability to give contact information including permanent residence or provide evidence of stable living environment for the study period.
  5. Active weight reduction of more than 7 pounds in the last 3 months.
  6. History of bleeding or blood clotting disorders.
  7. Pregnancy or breast-feeding in the women.
  8. History of anaphylaxis or anaphylactoid-like reaction as a result of food allergies.
  9. HIV or hepatitis B and C positive subjects.
  10. Subjects with hemoglobin <8.5 gm/dl.
  11. Abnormal Liver function test (ALT, AST, Alkaline phosphate, LDH, GGT or Total Bilirubin).
  12. Serum creatinine or BUN greater than the upper limit of the normal, serum albumin less than 3.5g/dl, or proteinuria 1+ or greater.
  13. History of alcohol intake of more than 40 g/day.
  14. Contraindications to MRI including pacemakers, surgical clips, metallic implants, neuromuscular- skeletal stimulators and internal orthopedic screws or rods.

    -

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00229255

Allegra Grossman, MD      212-327-7018    agrossman@rockefeller.edu

New York
      Rockefeller University Hospital, New York,  New York,  10021,  United States; Recruiting
Allegra Grossman, MD  212-327-7018    agrossman@rockefeller.edu 
Markus Stoffel, MD, PHD,  Principal Investigator

Study chairs or principal investigators

Markus Stoffel, MD, PHD,  Principal Investigator,  Rockefeller University   

More Information

http://www.rucares.org:8001/rucares/admin/form.php?id

Study ID Numbers:  MST-0557-0305
Last Updated:  July 24, 2006
Record first received:  September 27, 2005
ClinicalTrials.gov Identifier:  NCT00229255
Health Authority: United States: Food and Drug Administration
Related Articles
 
 


Warning: fopen(/home/agape25/public_html/rssw/rwdcache) [function.fopen]: failed to open stream: Permission denied in /home/agape25/public_html/rssw/rsswload.php on line 175

Warning: fwrite(): supplied argument is not a valid stream resource in /home/agape25/public_html/rssw/rsswload.php on line 176

Warning: fclose(): supplied argument is not a valid stream resource in /home/agape25/public_html/rssw/rsswload.php on line 177

Recent News and Updated Items

Rent a PO Box Without Leaving Your Home
Find, and now rent, a Post Office Box along with the morning cup of coffee or after putting the kids to bed at night. Read More

Airborne Refunds: Eligible Consumers Have 11 Days to Apply for Airborne Refunds
September 15 is the last day for eligible consumers who purchased Airborne products over a six-year period to apply for refunds. Details on eligibility can be found at &#8230;Read More

jen-e.php



 

United States Government News
Latest Headlines


Melamine and Melamine Related Compunds Alert: FDA Issues Interim Safety and Risk Assessment
U.S. and Georgia Business Summit to be held in Tbilisi, Georgia on October 26-28
Foreclosure Prevention: HUD Announces $50 Million In Housing Counseling Grants To Nearly 400 National, State And Local Agencies
U.S. Customs is Hiring: Recruitment Fair October 4
Melamine Alert: Mr. Brown 3-In-1 & and 2-In-1

obesity treatment morbid obesity,overeating, bariatric center,bariatric surgury,bariatric clinics,bariatric centers,bariatric doctors,bariatric surgery